BIOMAT Database Logo BIOMAT Database Logo

The use of fluphenazine enanthate in psychotic patients. 1973

K G Routsonis, and H Photiadis

UI MeSH Term Description Entries
D008297 Male Males
D005260 Female Females
D005476 Fluphenazine A phenothiazine used in the treatment of PSYCHOSES. Its properties and uses are generally similar to those of CHLORPROMAZINE. Flufenazin,Fluphenazine Hydrochloride,Lyogen,Prolixin,Hydrochloride, Fluphenazine
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D001480 Basal Ganglia Diseases Diseases of the BASAL GANGLIA including the PUTAMEN; GLOBUS PALLIDUS; claustrum; AMYGDALA; and CAUDATE NUCLEUS. DYSKINESIAS (most notably involuntary movements and alterations of the rate of movement) represent the primary clinical manifestations of these disorders. Common etiologies include CEREBROVASCULAR DISORDERS; NEURODEGENERATIVE DISEASES; and CRANIOCEREBRAL TRAUMA. Extrapyramidal Disorders,Basal Ganglia Disorders,Lenticulostriate Disorders,Basal Ganglia Disease,Basal Ganglia Disorder,Extrapyramidal Disorder,Lenticulostriate Disorder
D012559 Schizophrenia A severe emotional disorder of psychotic depth characteristically marked by a retreat from reality with delusion formation, HALLUCINATIONS, emotional disharmony, and regressive behavior. Dementia Praecox,Schizophrenic Disorders,Disorder, Schizophrenic,Disorders, Schizophrenic,Schizophrenias,Schizophrenic Disorder

Related Publications

K G Routsonis, and H Photiadis
Fluphenazine enanthate in the treatment of psychotic patients.
June 1966, International journal of neuropsychiatry,
K G Routsonis, and H Photiadis
Acute psychotic episodes in patients treated with fluphenazine enanthate.
November 1969, The British journal of psychiatry : the journal of mental science,
K G Routsonis, and H Photiadis
Fluphenazine enanthate for the difficult psychotic patient.
February 1969, Diseases of the nervous system,
K G Routsonis, and H Photiadis
Fluphenazine enanthate: a report of a clinical trial in psychotic patients.
April 1968, Current therapeutic research, clinical and experimental,
K G Routsonis, and H Photiadis
A controlled comparative study of fluphenazine and fluphenazine enanthate in acute and chronic psychotic patients.
January 1970, Psychiatria, neurologia, neurochirurgia,
K G Routsonis, and H Photiadis
Fluphenazine enanthate in the treatment of chronic psychotic patients: a controlled clinical study.
February 1971, Internationale Zeitschrift fur klinische Pharmakologie, Therapie, und Toxikologie. International journal of clinical pharmacology, therapy, and toxicology,
K G Routsonis, and H Photiadis
[Fluphenazine enanthate].
September 1966, Revista brasileira de medicina,
K G Routsonis, and H Photiadis
Long acting phenothiazines and long term psychotic patients: the role of fluphenazine enanthate in treatment.
September 1970, Diseases of the nervous system,
K G Routsonis, and H Photiadis
Fluphenazine use with chronic psychotic patients.
April 1961, Diseases of the nervous system,
K G Routsonis, and H Photiadis
Fluphenazine enanthate ... its use in the treatment of schizophrenia.
December 1968, The Canadian journal of psychiatric nursing,
Copied contents to your clipboard!